The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
prostrate cancer
Comments
-
-
-
===========================================================
Collected: 2/13/2023 Received: 2/13/2023 Reported: 2/14/2023
A. PROSTATE, LEFT BASE, BIOPSY: Benign prostate tissue with HIFU therapy related changes.
B. PROSTATE, LEFT MIDDLE, BIOPSY: Benign prostate tissue with HIFU therapy related
changes.
C. PROSTATE, LEFT APEX, BIOPSY: Benign prostate tissue with HIFU therapy related changes.
D. PROSTATE, LEFT LATERAL BASE, BIOPSY: Benign prostate tissue with HIFU therapy related
changes.
E. PROSTATE, LEFT LATERAL MIDDLE, BIOPSY: Benign prostate tissue with HIFU therapy
related changes.
F. PROSTATE, LEFT LATERAL APEX, BIOPSY: Benign prostate tissue with HIFU therapy related
changes.
G. PROSTATE, RIGHT BASE, BIOPSY:
PROSTATIC ADENOCARCINOMA without treatment effect, Grade Group 1 (Gleason Score 3 + 3 =
6), involving 10% of one (1) core.
Total linear length of cancer is 1 mm.
H. PROSTATE, RIGHT MIDDLE, BIOPSY:
SMALL FOCUS OF PROSTATIC ADENOCARCINOMA without treatment effect, Grade Group 1 (Gleason
score 3 + 3 = 6), involving less than 5% of one (1) core.
I. PROSTATE, RIGHT APEX, BIOPSY:
PROSTATIC ADENOCARCINOMA without treatment effect, Grade Group 2 (Gleason Score 3 + 4 =
7), involving 20% of the total fragmented specimen.
Percentage of Gleason pattern 4 = 10%.
The pattern 4 of this carcinoma lacks a large cribriform morphology.
J. PROSTATE, RIGHT LATERAL BASE, BIOPSY:
SMALL FOCUS OF PROSTATIC ADENOCARCINOMA without treatment effect, Grade Group 1 (Gleason
score 3 + 3 = 6), involving less than 5% of one (1) core.
K. PROSTATE, RIGHT LATERAL MIDDLE, BIOPSY:
PROSTATIC ADENOCARCINOMA without treatment effect, Grade Group 1 (Gleason Score 3 + 3 =
6), discontinuously involving 80% of one (1) core.
Total linear length of cancer is 2 mm.
L. PROSTATE, RIGHT LATERAL APEX, BIOPSY:
PROSTATIC ADENOCARCINOMA without treatment effect, Grade Group 1 (Gleason Score 3 + 3 =
6), involving 50% of one (1) core.
Total linear length of cancer is 4 mm.
-
-
-
From your report…”discontinuously involving 80% of one (1) core.”
MRIs pick up where the cancer is collected in one spot (lesion). You have cancer where it is scattered throughout your prostate. Discontinuous. That’s not as likely to show up. It is also, I think, more dangerous, since your cancer seems to want to spread out.
-
Hey Guys,
Here I am again. I opted for AS. I am very concerned that PSA is steadily rising.
5/6/228/9/2211/8/224/13/238/22/23
2.100/ 1.580/ 1.970/ 3.570/ 5.420 H
I am not really sold on treatment due to life changing side effects and possible recurrence.
I posted treatments I had before, HIFU left side. PSA went down but all of a sudden going back up quickly. I had a biopsy which revealed a 3/4 and several 3/3 on the right side. I reason given for not total ablation was the 3/3 on the right was not a concern at the time. (3/4 on right side).
Any comments. I love my sex life even at 70 YRS.
-
Several of us posted earlier that therapy should be considered because cancerous foci have been detected. Note that there could be more because a biopsy samples only a small portion of the prostate. Consequently, a rise in PSA is not unexpected and it's likely that your PSA will continue to go up beyond the current value (5.4 ng/ml). You really don't want the cancer to spread outside of the prostate!
Whereas surgery MAY have consequences, several radiation therapies are unlikely to affect your sex life long-term. Please read up on brachytherapy (there are two kinds), Stereotactic Body Radiation Therapy SBRT) and Intensity-Modulated Radiation Therapy (IMRT). After you have become somewhat familiar with these therapies, please consult the best radiation oncologist you can find to get his/her advice.
You can also consult with the Johns Hopkins Active Surveillance group to see whether you CAN continue with AS. What does your current AS program recommend?
Best wishes on the path forward.
-
Had a NM Pet/Ct Skull Base To Thigh: results:
Impression
1. PSMA avid lesion involving the prostate gland on left side consistent with a primary prostatic neoplasm.
2. PSMA avid subcentimeter left external iliac lymph node consistent with a metastasis.
Gallium-68 PSMA PET/CT SCAN
DATE: 10/13/2023
INDICATION: Malignant neoplasm of the prostate
FINDINGS:
Head/Neck:
* No significant Gallium-68 PSMA avid abnormality is identified in the image portion of the head.
* Streak artifact limits evaluation of the oral cavity.
Chest:
* Limited assessment of the lungs, due to low dose, thick slices, low lung volume technique obtained during shallow breathing.
Mediastinum/Hilar:
* No evidence of any abnormal Gallium-68 PSMA avid mediastinal lymphadenopathy.
* No evidence of any abnormal Gallium-68 PSMA avid hilar lymphadenopathy.
Axilla:
* Right axillary lymph node with SUV 2.0.
Lungs:
* No evidence of any abnormal Gallium-68 PSMA avid lung nodules. Left lung base atelectasis.
Pleura:
* No evidence of pericardial/pleural effusion.
Chest wall:
* Unremarkable.
Abdomen/Pelvis:
* Liver: No suspicious focal Gallium-68 PSMA avid lesion identified within the liver.
* Gallbladder: Gallbladder is unremarkable.
* Spleen: No suspicious focal Gallium-68 PSMA avid lesion identified within the spleen.
* Gastrointestinal tract:
* Stomach: Unremarkable.
* Bowel: Nonspecific bowel uptake is identified
* Pancreas: Physiologic uptake identified.
* Lymphadenopathy: Left external iliac lymph node, subcentimeter in size, SUV 16.1.
* Peritoneum / mesentery: No abnormal Gallium-68 PSMA avid masses or lymph nodes seen in the abdomen or pelvis.
* Kidneys, ureters and bladder: Unremarkable.
* Prostate gland: Intense focal radiotracer uptake in the left prostate mid gland, SUV 7.6.
Musculoskeletal:
* Nonspecific Gallium-68 PSMA uptake is seen throughout the osseous structures with no focal uptake identified.
* Multilevel degenerative changes are identified.
* Right lower extremity intramuscular focus of increased uptake with SUV of 2.8.
Skin/Subcutaneous tissue:
* No abnormal Gallium-68 PSMA avid lessions found:
Any comments: take note of last item and I was concerned about the right side. The test make no mention of right side
only the HIFU left side!
-
-
Discussion Boards
- All Discussion Boards
- 6 Cancer Survivors Network Information
- 6 Welcome to CSN
- 122.5K Cancer specific
- 2.8K Anal Cancer
- 456 Bladder Cancer
- 312 Bone Cancers
- 1.7K Brain Cancer
- 28.6K Breast Cancer
- 408 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13.1K Head and Neck Cancer
- 6.4K Kidney Cancer
- 681 Leukemia
- 803 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 242 Multiple Myeloma
- 7.2K Ovarian Cancer
- 69 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 743 Skin Cancer
- 659 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.4K Lifestyle Discussion Boards